Key facts
- IM Cannabis Corp. filed a Form 6K on June 3.
- The filing includes details on a $225,000 convertible note financing.
- CEO Yoni Melzer acquired approximately 2.5 million shares of common stock.
IM Cannabis Corp. (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, filed a Form 6K with the U.S. Securities and Exchange Commission (SEC) on June 3, 2024. The filing provides updated information to shareholders. The company announced the closing of a $225,000 convertible note financing, which was completed through a private placement. In a separate announcement, the company stated that its CEO, Yoni Melzer, has acquired approximately 2.5 million shares of common stock.